ABSCI CORPORATION - COMMON STOCK

Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference

08 Jan 2023 15:13:30 By Nasdaq GlobeNewswire

Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference

28 Dec 2022 08:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Berenberg Discover AI Seminar

23 Nov 2022 08:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Stifel Healthcare Conference

02 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

Absci Welcomes Meta Senior Executive to Board of Directors

02 Nov 2022 08:00:01 By Nasdaq GlobeNewswire

Absci to Participate in the 31st Annual Credit Suisse Healthcare Conference

26 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer

04 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Morgan Stanley Global Healthcare Conference

01 Sep 2022 08:00:01 By Nasdaq GlobeNewswire

Absci to Participate at the Inaugural Gilmartin Group Emerging Growth Company Showcase

24 Aug 2022 07:00:00 By Nasdaq GlobeNewswire

Absci Reports Second Quarter 2022 Financial Results and Business Update

11 Aug 2022 08:00:01 By Nasdaq GlobeNewswire

Absci to Participate in the SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare Event

21 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing Hires

14 Jul 2022 07:05:00 By Nasdaq GlobeNewswire

Absci Enters Multi-Program Collaboration with Emerging Biotech Partner

07 Jul 2022 07:05:00 By Nasdaq GlobeNewswire

Absci Reports First Quarter 2022 Financial and Operating Results

11 May 2022 08:00:02 By Nasdaq GlobeNewswire

Absci to Participate in the BofA Securities 2022 Healthcare Conference

28 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

Absci Expands Drug Discovery Capabilities with Opening of Absci AI Research Lab in New York City

20 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

Absci Reports Full Year 2021 Financial and Operating Results

22 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by NVIDIA

22 Mar 2022 13:00:00 By Nasdaq GlobeNewswire

Absci Appoints Dr. Andreas Busch to Board of Directors

21 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Absci to Present at Global AI Conference NVIDIA GTC

16 Mar 2022 08:00:01 By Nasdaq GlobeNewswire